Lomitapide Shows Promise in Pediatric Homozygous FH
Children and adolescents with homozygous familial hypercholesterolemia could benefit from lomitapide therapy, suggests a trial, although safety concerns and upcoming novel drugs question its place.
Stay updated with breaking news from Metabolism Unit. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Children and adolescents with homozygous familial hypercholesterolemia could benefit from lomitapide therapy, suggests a trial, although safety concerns and upcoming novel drugs question its place.
Guy Goodwin of COMPASS Pathways, explores the potential of tryptamines / psilocybin therapy in treatment resistant depression.
15.08.2022 - Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) (“Navidea” or the “Company”), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today announced its financial results for the second quarter and ...
The first study of its kind shows regional global disparities in COVID-19 vaccination rates among people with HIV, who are at higher risk for COVID-19 mortality.
The AIDS Clinical Trials Group, the largest global HIV research network, which recently expanded its focus to include evaluating outpatient treatment for COVID-19, today announced that insights around COVID-19 vaccination rates among people living with HV have been published in the Journal of Infectious Diseases.